60 Degrees Pharmaceuticals (SXTPW) Competitors $0.09 +0.01 (+14.53%) As of 09:54 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock SXTPW vs. ATNFW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, CLNNW, and COEPWShould you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include 180 Life Sciences (ATNFW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. 60 Degrees Pharmaceuticals vs. Its Competitors 180 Life Sciences Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene Coeptis Therapeutics 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings. Does the media favor SXTPW or ATNFW? In the previous week, 60 Degrees Pharmaceuticals and 60 Degrees Pharmaceuticals both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 1.97 beat 180 Life Sciences' score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment 60 Degrees Pharmaceuticals Very Positive 180 Life Sciences Neutral Which has higher valuation & earnings, SXTPW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio60 Degrees Pharmaceuticals$641.41KN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is SXTPW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets 60 Degrees PharmaceuticalsN/A N/A N/A 180 Life Sciences N/A N/A N/A Summary60 Degrees Pharmaceuticals beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Get 60 Degrees Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTPW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTPW vs. The Competition Export to ExcelMetric60 Degrees PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$151.42M$5.74B$9.77BDividend YieldN/A3.74%4.40%4.08%P/E RatioN/A3.8730.4126.04Price / SalesN/A3,993.95428.97104.72Price / CashN/A13.1925.7828.79Price / BookN/A52.159.706.08Net IncomeN/A-$90.99M$3.27B$265.64M7 Day PerformanceN/A9.31%3.94%3.11%1 Month PerformanceN/A11.14%3.81%0.39%1 Year PerformanceN/A214.91%31.26%18.52% 60 Degrees Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTPW60 Degrees PharmaceuticalsN/A$0.09+14.5%N/A+104.8%$0.00$641.41K0.002Positive NewsATNFW180 Life SciencesN/A$0.38+256.8%N/A+2,400.6%$0.00N/A0.007Positive NewsGap DownHigh Trading VolumeDRTSWAlpha Tau MedicalN/A$0.27+3.8%N/A+20.8%$0.00N/A0.0080APLMWApollomicsN/A$0.03+17.6%N/A+29.0%$0.00N/A0.0059Positive NewsGap DownBCTXWBriaCell TherapeuticsN/A$0.02-10.8%N/A-93.3%$0.00N/A0.008Positive NewsGap UpHigh Trading VolumeCDIOWCardio DiagnosticsN/A$0.01-0.7%N/A-60.6%$0.00$19.90K0.007Positive NewsCELUWCelularityN/A$0.05+1.1%N/AN/A$0.00$54.22M0.00220Positive NewsGap UpCEROWCERo TherapeuticsN/A$0.02+19.4%N/AN/A$0.00N/A0.008CINGWCingulateN/A$0.07-6.3%N/A-21.8%$0.00N/A0.0020Gap UpCLNNWCleneN/A$0.03+0.4%N/AN/A$0.00$350K0.00100Gap UpCOEPWCoeptis TherapeuticsN/A$0.02flatN/A+6.5%$0.00$62.87K0.004Gap Down Related Companies and Tools Related Companies ATNFW Alternatives DRTSW Alternatives APLMW Alternatives BCTXW Alternatives CDIOW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives CLNNW Alternatives COEPW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTPW) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access